Melinta Therapeutics Announces Successful Completion of Merger
06 nov. 2017 08h00 HE
|
Melinta Therapeutics
NEW HAVEN, Conn., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial...